Macrogenics Inc (NAS:MGNX)
$ 4.36 0.25 (6.07%) Market Cap: 273.08 Mil Enterprise Value: 122.86 Mil PE Ratio: 0 PB Ratio: 2.57 GF Score: 60/100

MacroGenics Inc at Stifel Virtual Healthcare Conference Transcript

Nov 17, 2020 / 03:40PM GMT
Release Date Price: $21.5 (+1.49%)
Stephen Douglas Willey
Stifel, Nicolaus & Company, Incorporated, Research Division - Director

Hello, everyone. I'm Stephen Willey, one of the senior biotech analysts here at Stifel. Glad to have with us here this morning, presenting from MacroGenics is the Chief Executive Officer, Scott Koenig. He is going to -- we're just going to have an informal discussion here. I think that there's a chat function for anyone who's listening to populate some questions into, and we can get those asked and answered, I guess, as appropriate.

But Scott, I guess, before we get into Q&A, any kind of opening statements you want to make just with respect to kind of who you are, what you do and where you are?

Scott Koenig
MacroGenics, Inc. - CEO, President & Director

Thanks, Steve, and appreciate the invitation today. It's a very exciting time for the company. As you know, we've made tremendous progress during the year. Currently, we have 8 molecules in clinical development, Phase I to Phase III, have a very large preclinical portfolio. Our molecules are using

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot